Masimo Reschedules Date of First Quarter 2021 Financial Results Conference CallBusiness Wire • 04/19/21
Masimo to Report First Quarter 2021 Financial Results after Market Close on Tuesday, April 27Business Wire • 04/14/21
Masimo Announces FDA Clearance of Radius PCG™ for the Root® Patient Monitoring and Connectivity PlatformBusiness Wire • 04/12/21
Study Investigates the Effects of Ventilatory Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients Using Masimo O3®Business Wire • 04/06/21
Study Investigates the Impact of Automating Respiration Rate Measurement Using Masimo Rad-G™ with RRp®Business Wire • 03/29/21
Masimo (MASI) Down 10.2% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/25/21
Sri Lankan Study Expands Evidence Demonstrating the Benefits of Critical Congenital Heart Disease (CCHD) Screening Using Masimo SET® Pulse OximetryBusiness Wire • 03/22/21
New Study Evaluates the Ability of Masimo EMMA® Capnography to Assess the Respiratory Status of Children With TracheostomyBusiness Wire • 03/15/21
4 Stocks to Watch as FDA Action Plan Stresses MedTech DigitizationZacks Investment Research • 03/05/21
Masimo to Present in Raymond James 42nd Annual Institutional Investors ConferenceBusiness Wire • 02/24/21
Masimo Corporation's (MASI) CEO Joe Kiani on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/24/21